Edition:
United Kingdom

Immune Design Corp (IMDZ.OQ)

IMDZ.OQ on NASDAQ Stock Exchange Global Market

3.25USD
17 Aug 2018
Change (% chg)

$0.10 (+3.17%)
Prev Close
$3.15
Open
$3.15
Day's High
$3.40
Day's Low
$3.08
Volume
113,871
Avg. Vol
39,794
52-wk High
$11.20
52-wk Low
$2.80

Select another date:

Wed, May 2 2018

BRIEF-Immune Design Q1 Loss Per Share $0.28

* IMMUNE DESIGN REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design Reports Q4 Loss Per Share $0.29

* IMMUNE DESIGN REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

BRIEF-Immune Design Reports Data Update For Lead Immunotherapy Programs

* IMMUNE DESIGN REPORTS DATA UPDATE FOR LEAD IMMUNOTHERAPY PROGRAMS: IMPROVEMENT IN SURVIVAL FOR CMB305 MONOTHERAPY IN SARCOMA AND INCREASED OBJECTIVE RESPONSES FOR G100/PEMBROLIZUMAB COMBINATION IN FOLLICULAR LYMPHOMA

BRIEF-Immune Design To Report Q4 And Year End 2017 Financial Results And Provide Corporate Update

* IMMUNE DESIGN TO REPORT FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS AND PROVIDE CORPORATE UPDATE Source text for Eikon: Further company coverage:

Select another date: